Skip to main content
Livermore
Livermore
ZHEN

Beam Therapeutics Inc.

BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001745999

In the last 90 days, Beam Therapeutics Inc. insiders filed 0 open-market purchases and 3 sales; 277 institutions reported holding it in 13F filings for Q2 2026, worth $3.75B in total; superinvestors ARK Invest and Duquesne Family Office hold it.

Superinvestors holding BEAM, Q2 2026

2 superinvestors report holding Beam Therapeutics Inc. on Form 13F, worth $356.5M in total. Weight is Beam Therapeutics Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding BEAM in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
ARK InvestCathie Wood2.3%10,234,862$351.3MReduced−15.6%
Duquesne Family OfficeStanley Druckenmiller0.1%153,600$5.27MNew

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of BEAM each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    2 superinvestors holding at quarter end

    New
    Duquesne Family Office
    Reduced
    ARK Invest (−15.6%)

  2. Q1 2026

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−2.7%)

  3. Q4 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+12.9%)

  4. Q3 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+24.8%)

  5. Q2 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+4.3%)

  6. Q1 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+20.0%)

  7. Q4 2024

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+8.2%)

  8. Q3 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−14.4%)

  9. Q2 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−6.8%)

  10. Q1 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−12.9%)

  11. Q4 2023

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+6.9%)

  12. Q3 2023

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+4.8%)

  13. Q2 2023

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−2.2%)

  14. Q1 2023

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+4.4%)

  15. Q4 2022

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−3.3%)

  16. Q3 2022

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−3.4%)

  17. Q2 2022

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+7.2%)

  18. Q1 2022

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+2.7%)

  19. Q4 2021

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+16.7%)
    Sold out
    HHLR Advisors (Hillhouse)

  20. Q3 2021

    2 superinvestors holding at quarter end

    Added
    ARK Invest (+5.9%)
    Reduced
    HHLR Advisors (Hillhouse) (−21.5%)

  21. Q2 2021

    2 superinvestors holding at quarter end

    Added
    ARK Invest (+35.2%)
    Reduced
    HHLR Advisors (Hillhouse) (−10.9%)
    Sold out
    Maverick Capital